Buyback update: 29,115 shares purchased on October 27, 2026

Corporate Actions View source PDF Explain this filing

ADVENZYMES · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.5%Reaction day

₹260.55

prior close

₹258.30

announcement price

After-mkt

timing

Nifty Microcap 250marketpendingvs market: pending

Biotechnology peers, median of 5sector+0.0%+0.5% vs sector

On the reaction day the stock moved 0.5 pts more than its Biotechnology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.8

15m

+0.3

30m

+0.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.5pendingpending+0.0+0.5

Next day

+2.1pendingpending+2.2-0.1

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Biotechnology peers, median of 5Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The company bought back 29,115 equity shares of Rs 2 each on October 27, 2026 through the open market at an average price of Rs 256.4868 per share, excluding transaction costs. Cumulative buybacks reached 2,291,868 shares, with no previously bought shares closed out during the day.

Likely market impact

The buyback reduces shares available for sale and may support investor confidence, but the filing gives no direct guidance on price or future purchases.